Cancer is one of the most significant health issues facing the UK with 50 per cent of the population expected to suffer from the disease during their lifetime. It is also a critical area of focus for the Imperial College AHSC.

The partnership draws on the strengths of the Royal Marsden NHS Foundation Trust a specialist cancer centre renowned for its research and clinical care, the academic excellence of Imperial College London and the Institute of Cancer Research, and comprehensive cancer services for the local North West London population provided by the other AHSC NHS partners.

To support AHSC objectives to reduce the impact of cancer by developing new approaches to the prevention and early detection of the disease Imperial and the Institute of Cancer Research have established a joint centre, the Cancer Epidemiology & Prevention Research Unit, and early detection of cancer is a priority theme in the CRUK Convergence Science Centre.

The AHSC has an extensive portfolio of multidisciplinary research across tumour types and spanning the translational pathway, delivered through the:

As well as an active research programme the AHSC partners are championing the implementation of new models of cancer care delivery through RM Partners, an NHS England Vanguard initiative.